Compassionate use study of MTX110 in Diffuse Intrinsic Pontine Glioma (DIPG) patients

Trial Profile

Compassionate use study of MTX110 in Diffuse Intrinsic Pontine Glioma (DIPG) patients

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 Sep 2016

At a glance

  • Drugs MTX 110 (Primary)
  • Indications Glioma
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 22 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top